LAUREN CASTILLO: Open Payments
NPI 1831650621 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 5 payments from 4 companies in 2025. Trend: 2023 $472 · 2024 $218 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $105 |
| Exelixis Inc. | 2 | $57 |
| Ferring Pharmaceuticals Inc. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: Wegovy, CABOMETYX, ADSTILADRIN, ERLEADA.
Industry payments across TX — which companies pay providers there.
